Mohamad Chaaban, MD

Appointed
2019

Education & Fellowships

Graduate School - Drexel University
Masters Clinical Research
Philadelphia, PA USA
2014

Fellowship - The University of Alabama Hospital
Rhinology
Birmingham, AL USA
2012

Residency - The University of Chicago
Otorhinolaryngology- Head and Neck Surgery
Chicago, IL USA
2011

Internship - Henry Ford Hospital
Transitional
Detroit, MI USA
2007

Medical Education - American University of Beirut
Beirut, Lebanon
2006

Graduate School - American University of Beirut
Beirut, Lebanon
2006

Undergraduate - American University of Beirut
Beirut, Lebanon
2002

Additional Training

• Rhinology and Minimally Invasive Skull Base Surgery

Certifications

• Otolaryngology - Head and Neck Surgery

Specialty Interests

Minimally invasive skull base surgery CSF leaks Nasal polyposis, primary and revision functional endoscopic sinus surgery Inverted papilloma Sinus tumors Sinus Osteomas Recalcitrant Chronic Rhinosinusitis Fungal Rhinosinusitis Aspirin Exacerbated Respiratory Disease (AERD or Samter's triad) Hereditary Hemorrhagic Telangiectasia (HTT or Osler–Weber–Rendu syndrome)

Awards & Honors

• 2018-American Academy of Otolaryngology-Head and Neck Surgery Foundation, Cochrane Scholars Award
• 2018-Byron Bailey Surgical Society Teaching Excellence Award
• 2018-American Academy of Otolaryngic Allergy Research Grant
• 2018-Texas Super Doctors Rising Stars
• 2019-Texas Super Doctors Rising Stars

See publications for Mohamad Chaaban, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/22/2023, Dr. Chaaban has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.